BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21514265)

  • 21. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
    Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and analysis of circulating exosomal microRNA in human body fluids.
    Lässer C
    Methods Mol Biol; 2013; 1024():109-28. PubMed ID: 23719946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OncomiR detection in circulating body fluids: a PDMS microdevice perspective.
    Potrich C; Vaghi V; Lunelli L; Pasquardini L; Santini GC; Ottone C; Quaglio M; Cocuzza M; Pirri CF; Ferracin M; Negrini M; Tiberio P; De Sanctis V; Bertorelli R; Pederzolli C
    Lab Chip; 2014 Oct; 14(20):4067-75. PubMed ID: 25178053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of disseminated melanoma cells by reverse-transcription - polymerase chain reaction.
    Samija I; Lukac J; Kusić Z; Situm M; Samija M
    Coll Antropol; 2007 Dec; 31(4):1187-94. PubMed ID: 18217480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis.
    Ishii T; Fujiwara Y; Ohnaka S; Hayashi T; Taniguchi H; Takiguchi S; Yasuda T; Yano M; Monden M
    Ann Surg Oncol; 2004 Aug; 11(8):778-85. PubMed ID: 15289240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
    Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
    Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
    Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
    Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: effect of enzyme and sampling.
    Lin JC; Chen KY; Wang WY; Jan JS; Wei YH
    Head Neck; 2002 Jun; 24(6):591-6. PubMed ID: 12112557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
    Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
    Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
    Liu L; Liao GQ; He P; Zhu H; Liu PH; Qu YM; Song XM; Xu QW; Gao Q; Zhang Y; Chen WF; Yin YH
    Biochem Biophys Res Commun; 2008 Aug; 372(4):756-60. PubMed ID: 18514066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
    Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
    Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G; Tong D; Wolf A; Roka S; Leodolter S; Hoecker P; Fischer MB; Jakesz R; Zeillinger R
    Oncol Rep; 2005 Sep; 14(3):737-41. PubMed ID: 16077985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase RNA as a detection marker in the serum of breast cancer patients.
    Chen XQ; Bonnefoi H; Pelte MF; Lyautey J; Lederrey C; Movarekhi S; Schaeffer P; Mulcahy HE; Meyer P; Stroun M; Anker P
    Clin Cancer Res; 2000 Oct; 6(10):3823-6. PubMed ID: 11051224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aspiration biopsy RNA diagnosis].
    Takano T; Amino N
    Rinsho Byori; 2002 Nov; Suppl 123():156-62. PubMed ID: 12652804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capillary electrophoresis of a multiplex reverse transcription-polymerase chain reaction to target messenger RNA markers for body fluid identification.
    Haas C; Hanson E; Ballantyne J
    Methods Mol Biol; 2012; 830():169-83. PubMed ID: 22139660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids.
    Bai VU; Murthy S; Chinnakannu K; Muhletaler F; Tejwani S; Barrack ER; Kim SH; Menon M; Veer Reddy GP
    Int J Oncol; 2010 Feb; 36(2):443-50. PubMed ID: 20043080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
    Mecklenburg I; Weckermann D; Zippelius A; Schoberth A; Petersen S; Prang N; Riethmüller G; Kufer P
    J Immunol Methods; 2007 Jun; 323(2):180-93. PubMed ID: 17540401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.